Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 19, 2017
Pharmacy Choice - News - Drug Delivery Systems - September 19, 2017

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

9/12/17 - Easton Pharmaceuticals Announces That Its Partner Windsor Pharmaceuticals Has Received Regulatory Approvals For Products VS-Sense and AL-Sense For Central America and The Caribbean
Easton Pharmaceuticals Inc. and its JV partner BMV Medica SA de CV announces that its distributor Windsor Pharmaceuticals SA has received regulatory approval for two of its exclusively licensed Women's Health Care products for Central America and the Caribbean. After filing the regulatory documents subsequent to a signed sub-licensing agreement wit
9/12/17 - Glenmark gets USFDA approval for Rythmol SR generic [Algeria Press Service]
Glenmark Pharmaceuticals has received final approval from the US health regulator for generic version of Rythmol SR capsules, an anti-arrhythmic medication, which treats illnesses associated with rapid heart beats. "Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food& Drug Administration for Propafenone...
9/12/17 - Investigators at Technion-Israel Institute of Technology Discuss Findings in Drug Delivery Systems (Dielectrophoretic characterization and isolation...
Investigators at Technion-Israel Institute of Technology Discuss Findings in Drug Delivery Systems. According to news reporting from Haifa, Israel, by VerticalNews journalists, research stated, "Jellyfish stinging capsules known as nematocysts are explosive, natural-injection systems with high potential as a natural drug-delivery system.
9/12/17 - Revive Therapeutics Advances Research Program of Cannabinoid-Based Drug Delivery Technology for the Medical Marijuana and Pharmaceutical Markets
Revive Therapeutics Ltd., a company focused on the research, development and commercialization of novel treatments for serious and unmet medical needs, today announced the advancement of the research program with the University of Wisconsin-Madison to evaluate a novel drug delivery technology with a focus on cannabinoids for the potential to treat.
9/12/17 - Sage Therapeutics Reports Top-Line Results from Phase 3 STATUS Trial of Brexanolone in Super-Refractory Status Epilepticus
Sage Therapeutics, a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system disorders, today reported top-line results from its Phase 3 STATUS Trial of brexanolone in the treatment super-refractory status epilepticus. There are no treatments for SRSE currently approved by the U.S. Food and.
9/11/17 - ACTELION RECEIVES FDA APPROVAL OF TRACLEER FOR USE IN PEDIATRIC PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
Release date- 08092017- SOUTH SAN FRANCISCO, Calif- Actelion Pharmaceuticals US, Inc., one of the Janssen Pharmaceutical Companies of Johnson& Johnson, announced today that the U.S. Food and Drug Administration has approved a new 32 mg tablet for oral suspension for TRACLEER for use in pediatric patients aged three years and older with idiopathic o
9/11/17 - CURE Pharmaceutical Launches New Academic Partnership Program Providing the Company's Proprietary CureFilm for More Humane and Effective Animal Research
Release date- 08092017- OXNARD, Calif.- CURE Pharmaceutical,, a leading disruptive drug delivery technology company today announced the launch of a new academic partnership program, CureDotsTM. According to published research by the University of Southern California School of Pharmacy,' Utilizing an Orally Dissolving Strip for Pharmacological and..
9/11/17 - DiaMedica Announces the Initiation of Phase 2 Trial Evaluating DM199 (Recombinant Human KLK1) in Patients with Acute Ischemic Stroke
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company focused on improving lives of patients with neurological and kidney diseases associated with low KLK1 levels, announces its Phase 2 REMEDY clinical trial assessing the safety, tolerability, and markers of therapeutic activity of DM199 in patients suffering from acute ischemic
9/11/17 - Dr. Reddy's Laboratories announces the launch of Bupropion Hydrochloride Extended Release Tablets, USP in the U.S. Market
Release date- 08092017- Hyderabad, India and Princeton, NJ, USA.- Dr. Reddy's Laboratories Ltd. announced today that it has launched Bupropion Hydrochloride Extended Release Tablets, USP, 150 mg and 300 mg, a therapeutic equivalent generic version of Wellbutrin XL Tablets, approved by the U.S. Food& Drug Administration. About Dr. Reddy's: Dr. Reddy
9/11/17 - Dr. Reddy's Laboratories Announces the Launch of Cefixime for Oral Suspension, USP in the U.S. Market
By a News Reporter-Staff News Editor at Pharma Business Week Dr. Reddy's Laboratories Ltd. announced that it has launched Cefixime for Oral Suspension, USP 100 mg/5mL and 200 mg/5mL, a therapeutic equivalent generic version of Suprax for Oral Suspension, approved by the U.S. Food and Drug Administration. The Suprax brand and generic had U.S
9/11/17 - Dr. Reddy's Laboratories announces the launch of Metaxalone Tablets, USP in the U.S. Market
Release date- 08092017- Hyderabad, India and Princeton, NJ, USA- Dr. Reddy's Laboratories Ltd. announced today that it has launched Metaxalone Tablets, USP 800 mg, a therapeutic equivalent generic version of Skelaxin Tablets, approved by the U.S. Food and Drug Administration. About Dr. Reddy's: Dr. Reddy's Laboratories Ltd. is an integrated pharmac
9/11/17 - Findings on Drug Delivery Systems Discussed by Investigators at University of California (Micromotor-enabled active drug delivery for in vivo...
Findings on Drug Delivery Systems Discussed by Investigators at University of California. For more information on this research see: Micromotor-enabled active drug delivery for in vivo treatment of stomach infection. Nature Communications, 2017; 8: 71-79. Nature Communications can be contacted at: Nature Publishing Group, Macmillan Building, 4 Crin
9/11/17 - Five Prime Announces Updated Data in Mesothelioma Patients from Ongoing Phase 1b Trial of FP-1039 at ESMO 2017 Congress [Sport360]
-Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, announced that updated data from the ongoing Phase 1 b trial of FP-1039/GSK3052230 in mesothelioma patients were reported today in an oral presentation at the European Society for Medical...
9/11/17 - Global Drug Delivery Devices Market: Global Analysis and Opportunity Assessment 2017-2022
ReportsMonitor.Com Adds Global Drug Delivery Devices Market Professional Survey Report 2017 to Its Database. This report studies Drug Delivery Devices in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with...
9/11/17 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 36789) - Meeting
EVENT: Health and Human Services Department; Food and Drug Administration holds a meeting of the Oncologic Drugs Advisory Committee to discuss supplemental new drug application 021938/ 033 SUTENT oral capsules, submitted by C.P. Pharmaceuticals International C.V., represented by Pfizer, Inc., for the adjuvant treatment of adult patients at high ris
9/11/17 - LIPOCINE INC. (NASDAQ:LPCN) Files An 8-K Financial Statements and Exhibits
LIPOCINE INC. (NASDAQ:LPCN) Files An 8-K Financial Statements and ExhibitsItem 9.01 Financial Statements and Exhibits. The following exhibits are filed with this report: Exhibit No. Description 99.1 Rodman & Renshaw Presentation Lipocine Inc. ExhibitEX-99.1 2 v474863-ex99-1.htm EXHIBIT 99.1 Enabling oral drug delivery to improve patient compliance
9/11/17 - Multimedia Assets Now Available: Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah tisagenlecleucel, CTL019, for children...
Multimedia Assets Now Available: Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah tisagenlecleucel, CTL019, for children and young adults with B-cell ALL that is refractory or has relapsed at least twice. By a News Reporter-Staff News Editor at Cancer Vaccine Week Novartis announced that the US Food and Drug Administrat
9/11/17 - New Findings from Southwest University in the Area of Drug Delivery Systems Reported (Novel Strategy Utilizing Extracellular Cysteine-Rich Domain of...
New Findings from Southwest University in the Area of Drug Delivery Systems Reported. According to news reporting originating in Chongqing, People's Republic of China, by NewsRx journalists, research stated, "The development of proteolysis-resistant D-peptide ligands for targeted drug/gene delivery has been greatly limited, due to the challenge tha
9/11/17 - Patent Application Titled "Methods and Compositions for Self-Regulated Release of Active Pharmaceutical Ingredient" Published Online (USPTO...
Patent Application Titled "Methods and Compositions for Self-Regulated Release of Active Pharmaceutical Ingredient" Published Online. By a News Reporter-Staff News Editor at Mental Health Weekly Digest According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventors Brzeczko, Albert W.;..
9/11/17 - Patent Issued for Aerosolization Apparatus for Inhalation Profile-Independent Drug Delivery (USPTO 9744318)
By a News Reporter-Staff News Editor at Pharma Business Week Novartis AG has been issued patent number 9744318, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventors are Chan, Leo; Ung, Keith Try; Weers, Jeffry G.. This patent was filed on December 14, 2012 and was published online on Augus
9/11/17 - Patent Issued for Aerosols for Sinunasal Drug Delivery (USPTO 9744314)
By a News Reporter-Staff News Editor at Pharma Business Week From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Keller, Manfred; Schuschnig, Uwe; Zimmermann, Johann; Luber, Martin; Bohm, Andreas, filed on August 27, 2014, was published online on August 29, 2017. The patent's assignee for patent number 9744314 is P
9/11/17 - Patent Issued for Controlled Drug Delivery (USPTO 9744272)
By a News Reporter-Staff News Editor at Biotech Business Week According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventors Li, Jianmin; Bucay-Couto, Weenna, filed on August 10, 2015, was published online on August 29, 2017. The assignee for this patent, patent number 9744272, is Boston Scient
9/11/17 - Patent Issued for Pre-Filled Syringe Identification Tag (USPTO 9744304)
By a News Reporter-Staff News Editor at Journal of Engineering According to news reporting originating from Alexandria, Virginia, by VerticalNews journalists, a patent by the inventors Swift, Robert W.; Wilson, Donald, filed on December 2, 2015, was published online on August 29, 2017. The assignee for this patent, patent number 9744304, is AMGEN
9/11/17 - Patent Issued for Respirable Agglomerates of Porous Carrier Particles and Micronized Drug (USPTO 9744178)
By a News Reporter-Staff News Editor at Pharma Business Week A patent by the inventors Hartman, Michael; Tarara, Thomas E; Teung, Patrick; Weers, Jeffry G, filed on August 17, 2016, was published online on August 29, 2017, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 9744178 is assigne
9/11/17 - Patent Issued for Tetracycline Compositions (USPTO 9744179)
By a News Reporter-Staff News Editor at Pharma Business Week From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Griffith, David C.; Boyer, Serge; Hecker, Scott; Dudley, Michael N., filed on December 5, 2014, was published online on August 29, 2017. The patent's assignee for patent number 9744179 is Rempex Pharmace
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415